Tahlita Zuiverloon MD, PhD

Tahlita Zuiverloon MD PhD is a young urologist at Erasmus University Rotterdam, in the Netherlands and currently a research fellow in the laboratory of Dr. Dan Theodorescu at the University of Colorado Comprehensive Cancer Center. Zuiverloon finished her training as a biomedical scientist and urologist at Leiden University in the Netherlands. She contributed to the development of urine-based FGFR3 mutation and methylation detection assays for the surveillance of NMIBC patients. These assays are currently being tested in a national randomized controlled trial in the Netherlands. Zuiverloon’s current research efforts are focused on the identification of biomarkers predicting response to intravesical BCG instillations and on predictors of neoadjuvant chemotherapy.